Compare UPS & GSK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | UPS | GSK |
|---|---|---|
| Founded | 1907 | 1715 |
| Country | United States | United Kingdom |
| Employees | N/A | N/A |
| Industry | Trucking Freight/Courier Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 85.4B | 96.1B |
| IPO Year | 1999 | N/A |
| Metric | UPS | GSK |
|---|---|---|
| Price | $107.18 | $50.43 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 20 | 2 |
| Target Price | ★ $108.11 | N/A |
| AVG Volume (30 Days) | ★ 4.5M | 4.2M |
| Earning Date | 01-27-2026 | 02-04-2026 |
| Dividend Yield | ★ 6.08% | 3.41% |
| EPS Growth | N/A | ★ 118.57 |
| EPS | ★ 6.47 | 1.79 |
| Revenue | ★ $89,483,000,000.00 | $43,237,357,842.00 |
| Revenue This Year | N/A | $6.70 |
| Revenue Next Year | N/A | $5.10 |
| P/E Ratio | ★ $16.68 | $27.52 |
| Revenue Growth | N/A | ★ 2.73 |
| 52 Week Low | $82.00 | $32.38 |
| 52 Week High | $136.99 | $51.46 |
| Indicator | UPS | GSK |
|---|---|---|
| Relative Strength Index (RSI) | 59.93 | 58.95 |
| Support Level | $105.15 | $47.62 |
| Resistance Level | $110.04 | $50.87 |
| Average True Range (ATR) | 2.14 | 0.81 |
| MACD | -0.14 | -0.10 |
| Stochastic Oscillator | 64.09 | 73.05 |
As the world's largest parcel delivery company, UPS manages a massive fleet of more than 500 planes and 100,000 vehicles, along with many hundreds of sorting facilities, to deliver an average of about 22 million packages per day to residences and businesses across the globe. UPS' domestic US package operations generate around 65% of total revenue, while international package makes up 20%. Air and ocean freight forwarding and contract logistics make up the remainder.
In the pharmaceutical industry, GSK ranks as one of the largest firms by total sales. The company wields its might across several therapeutic classes, including respiratory, antiviral, and vaccines, and has been growing its presence in oncology and immunology, as well. GSK uses joint ventures to gain additional scale in certain markets like HIV.